Corpus Intelligence EBITDA Bridge — ROXBURY PSYCHIATRIC HOSPITAL 2026-04-26 23:27 UTC
EBITDA Bridge — ROXBURY PSYCHIATRIC HOSPITAL
CCN 394050 | PA | 112 beds | Current EBITDA $4.6M → Pro Forma $5.6M (+$968K)
🛡️ Public data only — no PHI permitted on this instance.
EBITDA BRIDGE  ·  CCN 394050

ROXBURY PSYCHIATRIC HOSPITAL
value-creation walk.

7-lever RCM bridge from current EBITDA to pro-forma — denial / underpay / DAR / coding / contract / cost discipline / cash acceleration. Each lever shows current vs benchmark target with data provenance.

$18.4M
Net Revenue HCRIS
$4.6M
Current EBITDA COMPUTED
+$968K
RCM EBITDA Uplift
$5.6M
Pro Forma EBITDA
+526bps
Margin Improvement
$706K
WC Released (1x)

Bridge Realization Estimate

ML model predicts what fraction of the bridge is achievable (accuracy: 60%, n=5,839)

71%
Realization (B)
$968K
Modeled Uplift
$687K
Risk-Adjusted
-$281K
Execution Discount
Occupancy RateHigher Occupancy Rate increases execution likeliho
Revenue per BedLower Revenue per Bed reduces execution likelihood
Commercial Payer %Higher Commercial Payer % reduces execution likeli
Payer DiversityHigher Payer Diversity increases execution likelih
Bed CountBed Count has minimal effect on execution

Expected realization: 71% of modeled bridge. Strengths: Occupancy Rate, Payer Diversity. Risks: Revenue per Bed, Commercial Payer %. Risk-adjusted uplift: $0.7M (vs $1.0M modeled).

EBITDA Bridge — 7 RCM Levers

Each bar shows the annual EBITDA impact at full run-rate. Revenue levers increase top-line; cost levers reduce operating expense; cash acceleration releases working capital. Calibrated to published research bands (Denial 12%→5% = $8-15M on $400M NPR).

Cost to Collect
Cost Savings | 12mo ramp
$368K
+200bp
Denial Rate Reduction
Revenue | 12mo ramp
$364K
+198bp
A/R Days Reduction
Cash Accel | 9mo ramp
$224K
+122bp
Clean Claim Rate
Cost Savings | 6mo ramp
$12K
+6bp
Total EBITDA Impact$968K

Lever Detail

Each value shows its data source. SELLER = seller data room, DEFAULT = model default, BENCHMARK = P75 peer benchmark.

LeverCurrentTargetRevenueCostEBITDAWCRamp
Cost to Collect4.5% DEFAULT2.5% BENCHMARK$0$368K$368K$012mo
Denial Rate Reduction12.0% DEFAULT6.5% BENCHMARK$354K$10K$364K$012mo
A/R Days Reduction52.00 DEFAULT38.00 BENCHMARK$56K$167K$224K$706K9mo
Clean Claim Rate88.0% DEFAULT96.0% BENCHMARK$0$12K$12K$06mo
Net Collection Rate93.5% DEFAULT35.1% BENCHMARK$0$0$0$018mo
CDI / Case Mix Index135.0% DEFAULT142.0% BENCHMARK$0$0$0$018mo

Implementation Timing Curve

Linear ramp to full run-rate per lever. Month 0 = close date. Partners should expect 60-70% of total uplift realized by month 12.

LeverM0M3M6M9M12M18M24M36
Cost to Collect$0$92K$184K$276K$368K$368K$368K$368K
Denial Rate Reduction$0$91K$182K$273K$364K$364K$364K$364K
A/R Days Reduction$0$75K$149K$224K$224K$224K$224K$224K
Clean Claim Rate$0$6K$12K$12K$12K$12K$12K$12K
Cumulative$0$264K$527K$785K$968K$968K$968K$968K

Returns Sensitivity (IRR / MOIC)

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Green = exceeds 20% IRR hurdle. Amber = 15-20%. Red = below hurdle or loss. RCM uplift of $968K is added at exit.

Entry \ Exit9.0x10.0x11.0x11.5x12.0x
8.0x47% / 6.8x51% / 7.9x55% / 9.0x57% / 9.5x59% / 10.1x
9.0x41% / 5.6x46% / 6.6x50% / 7.6x52% / 8.1x54% / 8.6x
10.0x37% / 4.8x41% / 5.6x46% / 6.5x47% / 7.0x49% / 7.4x
11.0x32% / 4.0x37% / 4.8x41% / 5.6x43% / 6.0x45% / 6.5x
12.0x28% / 3.4x33% / 4.2x37% / 4.9x39% / 5.3x41% / 5.6x

Covenant Headroom (at 10x Entry, 6.5x Max Leverage)

8.5x
Entry Leverage
7.0x
Pro Forma Leverage
-0.5x
Headroom (turns)
-8%
EBITDA Cushion

Pro forma EBITDA can decline -8% before the 6.5x covenant trips. RCM uplift reduces leverage from 8.5x to 7.0x, adding 1.5 turns of cushion.

5-Year Value Creation Waterfall

EBITDA trajectory: 3% organic growth + RCM uplift ramp (full run-rate at month 18).

Base EBITDARCM UpliftTotalMargin
Entry$4.6M$4.6M25.2%
Year 1$4.8M+$646K$5.4M29.5%
Year 2$4.9M+$968K$5.9M32.0%
Year 3$5.1M+$968K$6.0M32.8%
Year 4$5.2M+$968K$6.2M33.7%
Year 5$5.4M+$968K$6.4M34.5%
$46.4M
Entry EV (10x)
$69.9M
Exit EV (11x)
$23.4M
Value Created
$6.4M
Exit EBITDA
$7.4M
Organic Growth
$9.7M
RCM Value Creation
$6.4M
Multiple Expansion

Achievement Sensitivity

What if we only achieve a fraction of each lever? 50% = conservative, 75% = base management case, 100% = plan, 120% = stretch.

Lever50%75%100%120%
Cost to Collect$184K$276K$368K$442K
Denial Rate Reductio$182K$273K$364K$437K
A/R Days Reduction$112K$168K$224K$269K
Clean Claim Rate$6K$9K$12K$14K
Total$484K$726K$968K$1.2M

Peer Context — Where This Hospital Sits

Key metrics vs 102 size-matched peers. Low percentile on margin/efficiency metrics = more room for improvement = larger bridge opportunity.

MetricHospitalP25P50P75Percentile
Op Margin25.2%-19.0%-6.2%7.5%
P99
Net-to-Gross34.9%17.5%26.3%35.1%
P73
Occupancy78.2%39.6%59.0%76.2%
P76
Rev/Bed$164K$477K$801K$1.3M
P2
Exp/Bed$123K$441K$942K$1.4M
P0

Bridge Methodology

Coefficients calibrated to published research bands: denial 12%→5% = $8-15M on $400M NPR. Current metrics estimated from HCRIS public data and ML predictions. Target metrics set at P75 peer benchmarks with 60% gap closure assumption. Revenue levers use NPR × delta × avoidable share. Cost levers use claims volume × cost per reworked claim. Working capital from AR reduction is one-time cash (not included in recurring EBITDA). Returns assume 5.5x leverage, 3% organic growth, 10%/yr debt paydown.

Data: HCRIS FY2022 | 6,123 hospitalsSources: HCRISML